Pancreatic Cancer Research

ErratumCell Death Dis2025

Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.

Journal
Cell Death Dis
Published
25 April 2025
Citations
0
Type
Erratum
License
cc by
Full text
Open access, reuse-licensed (cc by)

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try